$338 Million is the total value of Sands Capital Ventures, LLC's 23 reported holdings in Q3 2023. The portfolio turnover from Q2 2023 to Q3 2023 was 0.0% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
Sell | SAMSARA INC | $23,564,720 | -44.9% | 934,737 | -39.4% | 6.97% | -44.9% | |
CFLT | Sell | CONFLUENT INC | $34,377 | -28.1% | 1,161 | -14.3% | 0.01% | -28.6% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-11-14
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
UIPATH INC | 9 | Q3 2023 | 30.2% |
DOORDASH INC | 9 | Q3 2023 | 19.6% |
SNOWFLAKE INC | 9 | Q3 2023 | 14.4% |
ACUMEN PHARMACEUTICALS, INC | 9 | Q3 2023 | 10.0% |
908 DEVICES INC | 9 | Q3 2023 | 1.8% |
TARSUS PHARMACEUTICALS INC | 9 | Q3 2023 | 1.4% |
TAYSHA GENE THERAPIES INC | 9 | Q3 2023 | 2.0% |
CANDEL THERAPEUTICS, INC | 9 | Q3 2023 | 1.3% |
SPRUCE BIOSCIENCES INC | 9 | Q3 2023 | 0.7% |
ABSCI CORPORATION | 9 | Q3 2023 | 0.1% |
View Sands Capital Ventures, LLC's complete holdings history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2024-02-13 |
SC 13G/A | 2024-02-13 |
SC 13G | 2024-02-13 |
13F-HR | 2023-11-14 |
13F-HR | 2023-08-15 |
13F-HR | 2023-05-12 |
SC 13G/A | 2023-02-14 |
SC 13G/A | 2023-02-14 |
13F-HR | 2023-02-13 |
13F-HR | 2022-11-09 |
View Sands Capital Ventures, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.